Viridian Therapeutics Inc (VRDN NASDAQ) stock market data APIs
$18.7339
-0.48(-2.6%)
as of September 16, 2025
Try our APIs with
free plan!
Viridian Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company's product pipeline includes veligrotug, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R monoclonal antibodies targeting IGF-1R and engineered of half-life extension technology, which is in Phase 3 clinical trial for the treatment of TED. It also develops portfolio of engineered anti-neonatal Fc receptor inhibitors, such as VRDN-006 and VRDN-008 for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Prev. Close
18.7339
Open
18.2583
High
19.0046
Low
18.0107
52 wk Range
9.9-27.2
Market Cap
1 471 M
Shares Outstanding
81 662 K
Revenue
305 K
EPS
-1
Beta
0.584
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Viridian Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Viridian Therapeutics Inc data using free add-ons & libraries
Get Viridian Therapeutics Inc Fundamental Data
Viridian Therapeutics Inc Fundamental data includes:
- Net Revenue: 305 K
- EBITDA: -371 102 016
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: -1
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Viridian Therapeutics Inc News
New
Viridian (VRDN) Q2 Net Loss Widens 55%
Key Points Collaboration revenue (GAAP) edged up to $75 thousand, exceeding analyst expectations for GAAP revenue but remaining negligible due to Viridian’s pre-commercial status. Net loss (GAAP) w...
Viridian Partners With Kissei In $385 Mln Japan Deal For Thyroid Eye Disease Treatments
(RTTNews) - Viridian Therapeutics, Inc. (VRDN), a biopharmaceutical company, on Wednesday announced that it has entered an exclusive collaboration and licensing deal with Kissei Pharmaceutical to deve...
Viridian licenses thyroid eye disease treatments to Kissei in Japan
WALTHAM, Mass. - Viridian Therapeutics, Inc. (NASDAQ:VRDN), a clinical-stage biotechnology company with a market capitalization of $1.37 billion, has entered into an exclusive licensing agreement with...
Analysts See 19% Gains Ahead For FHLC
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, an...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
